Yep, zandant, as it has been run it is a bad business, but it still has some decent products that may never see the light of day. But still generates income for the insiders, so to speak.
A wise leader might try and sell all or part of B for ABSSSI and other bacterial infections to alfasigma, yes alfasigma. They have an interest in pathogens as they related to the many forms of IBD. But I said "wise," not greedy. I still think if we see a successful IBD test we may get an offer for the whole Brilacidin franchise. AF, while not a huge BP, if easily big enough to make a decent offer for the whole of IPIX. But just my opinion
News 
Market Data 
Discover 
AI
